Zinzino AB reported its preliminary sales results for the first quarter of 2026. Group revenue in the first quarter reached $96.8 million, a 26% year-over-year increase, while the Faun Pharma external sales division fell from approximately $751,000 to approximately $698,000. Zinzino March 2026 revenue, in particular, increased 29% year-over-year and reached $36.2 million.
South America, which includes Peru and Colombia, posted the highest year-over-year first quarter market improvement, with 413% growth. North America, which includes the US, Mexico and Canada, also reported significant momentum, with a 71% growth rate over the same quarter of 2025.
All markets, with the exception of East Europe (Czech Republic, Slovakia, Hungary, Poland, Romania), experienced positive market growth.
The post Zinzino Releases Preliminary Q1 2026 Sales Report first appeared on Direct Selling News.
